Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ACN
|
Johan Deblaere
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16 Added 0.03% |
-
|
Feb 14
2020 |
ACN
|
Simon Eaves
Group Chief Executive-Products |
SELL
Payment of exercise price or tax liability
|
Direct | 1 Reduced 0.01% |
$212
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Simon Eaves
Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct | 18 Added 0.19% |
-
|
Feb 14
2020 |
ACN
|
James O Etheredge
Chief Exec-North America |
SELL
Payment of exercise price or tax liability
|
Direct | 3 Reduced 0.02% |
$637
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
James O Etheredge
Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct | 17 Added 0.13% |
-
|
Feb 14
2020 |
ACN
|
Herbert Hainer
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5 Reduced 0.08% |
$1,062
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Herbert Hainer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9 Added 0.14% |
-
|
Feb 14
2020 |
ACN
|
Daniel T London
Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct | 5 Reduced 0.02% |
$1,062
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Daniel T London
Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct | 23 Added 0.1% |
-
|
Feb 14
2020 |
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3 Reduced 0.01% |
$637
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19 Added 0.08% |
-
|
Feb 14
2020 |
ACN
|
Nancy Mc Kinstry
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 4 Reduced 0.08% |
$850
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Nancy Mc Kinstry
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.15% |
-
|
Feb 14
2020 |
ACN
|
Domingo Miron
Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct | 2 Reduced 0.0% |
$425
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Domingo Miron
Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct | 14 Added 0.03% |
-
|
Feb 14
2020 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct | 14 Added 0.01% |
-
|
Feb 14
2020 |
ACN
|
Gilles Pelisson
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5 Reduced 0.06% |
$1,062
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Gilles Pelisson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9 Added 0.1% |
-
|
Feb 14
2020 |
ACN
|
Paula A Price
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2 Reduced 0.02% |
$425
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Paula A Price
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6 Added 0.07% |
-
|
Feb 14
2020 |
ACN
|
Venkata S M Renduchintala
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 3 Reduced 0.06% |
$637
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Venkata S M Renduchintala
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9 Added 0.19% |
-
|
Feb 14
2020 |
ACN
|
David Rowland
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 29 Reduced 0.13% |
$6,161
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
David Rowland
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 63 Added 0.28% |
-
|
Feb 14
2020 |
ACN
|
Arun Sarin
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2 Reduced 0.03% |
$425
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Arun Sarin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6 Added 0.1% |
-
|
Feb 14
2020 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6 Reduced 0.02% |
$1,275
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38 Added 0.15% |
-
|
Feb 14
2020 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 3 Reduced 0.02% |
$637
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 31 Added 0.25% |
-
|
Feb 14
2020 |
ACN
|
Frank Kui Tang
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 6 Reduced 0.07% |
$1,275
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Frank Kui Tang
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.09% |
-
|
Feb 14
2020 |
ACN
|
Tracey Thomas Travis
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2 Reduced 0.04% |
$425
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
Tracey Thomas Travis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7 Added 0.14% |
-
|
Feb 14
2020 |
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 30 Added 0.12% |
-
|
Feb 14
2020 |
ACN
|
John F Walsh
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2 Reduced 0.01% |
$425
$212.44 p/Share
|
Feb 14
2020 |
ACN
|
John F Walsh
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 21 Added 0.1% |
-
|
Feb 14
2020 |
ACN
|
Jaime Ardila
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9 Added 0.07% |
-
|
Feb 14
2020 |
CRWD
|
Capital G LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 175,366 Reduced 100.0% |
$11,449,646
$65.29 p/Share
|
Feb 14
2020 |
CRWD
|
Capital G LP
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 175,366 Added 50.0% |
-
|
Feb 14
2020 |
ALTG
|
B. Riley Financial, Inc.
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect | 36,054 Added 0.73% |
-
|
Feb 14
2020 |
ALTG
|
B. Riley Financial, Inc.
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 2,135,262 Reduced 6.58% |
-
|
Feb 14
2020 |
ALTG
|
B. Riley Financial, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,285,000 Added 13.34% |
-
|
Feb 14
2020 |
ALTG
|
B. Riley Financial, Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 370,000 Reduced 7.56% |
-
|
Feb 14
2020 |
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 24.12% |
$356,350
$142.54 p/Share
|
Feb 14
2020 |
SNX
|
Kevin M Murai
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 19.44% |
$67,450
$26.98 p/Share
|
Feb 14
2020 |
AMP
|
James M Cracchiolo
CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct | 76,096 Added 18.59% |
-
|
Feb 14
2020 |
AMP
|
James M Cracchiolo
CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct | 46,081 Reduced 15.19% |
$8,215,321
$178.28 p/Share
|
Feb 14
2020 |
AMP
|
James M Cracchiolo
CHAIRMAN AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 37,172 Reduced 11.15% |
$6,647,097
$178.82 p/Share
|
Feb 14
2020 |
AMP
|
Colin Moore
EVP & Global CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 10,815 Reduced 13.56% |
$1,933,938
$178.82 p/Share
|
Feb 14
2020 |